HK1140422A1 - A medicament comprising a carbostyril derivative and donepezil for treating alzheimers disease - Google Patents

A medicament comprising a carbostyril derivative and donepezil for treating alzheimers disease

Info

Publication number
HK1140422A1
HK1140422A1 HK10106804.1A HK10106804A HK1140422A1 HK 1140422 A1 HK1140422 A1 HK 1140422A1 HK 10106804 A HK10106804 A HK 10106804A HK 1140422 A1 HK1140422 A1 HK 1140422A1
Authority
HK
Hong Kong
Prior art keywords
donepezil
medicament
alzheimers disease
carbostyril derivative
treating alzheimers
Prior art date
Application number
HK10106804.1A
Other languages
English (en)
Chinese (zh)
Inventor
Heii Arai
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of HK1140422A1 publication Critical patent/HK1140422A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK10106804.1A 2007-05-22 2010-07-13 A medicament comprising a carbostyril derivative and donepezil for treating alzheimers disease HK1140422A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007135367 2007-05-22
PCT/JP2008/059763 WO2008143361A1 (en) 2007-05-22 2008-05-21 A medicament comprising a carbostyril derivative and donepezil for treating alzheimer's disease

Publications (1)

Publication Number Publication Date
HK1140422A1 true HK1140422A1 (en) 2010-10-15

Family

ID=39636992

Family Applications (2)

Application Number Title Priority Date Filing Date
HK10106804.1A HK1140422A1 (en) 2007-05-22 2010-07-13 A medicament comprising a carbostyril derivative and donepezil for treating alzheimers disease
HK16103366.2A HK1215384A1 (zh) 2007-05-22 2016-03-23 種用於治療阿爾茨海默氏症的包含喹諾酮衍生物和多奈呱齊的藥物

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK16103366.2A HK1215384A1 (zh) 2007-05-22 2016-03-23 種用於治療阿爾茨海默氏症的包含喹諾酮衍生物和多奈呱齊的藥物

Country Status (28)

Country Link
US (1) US20100298375A1 (ja)
EP (2) EP2937085B1 (ja)
JP (1) JP5153870B2 (ja)
KR (1) KR101441725B1 (ja)
CN (1) CN101754758B (ja)
AR (1) AR066664A1 (ja)
AU (1) AU2008253977B2 (ja)
BR (1) BRPI0811919A2 (ja)
CA (1) CA2687289C (ja)
CO (1) CO6251249A2 (ja)
CY (1) CY1116683T1 (ja)
DK (1) DK2157973T3 (ja)
ES (1) ES2545959T3 (ja)
HK (2) HK1140422A1 (ja)
HR (1) HRP20150843T1 (ja)
HU (1) HUE025902T2 (ja)
IL (1) IL202053A (ja)
MX (1) MX2009012583A (ja)
MY (1) MY146407A (ja)
NZ (1) NZ581099A (ja)
PL (1) PL2157973T3 (ja)
PT (1) PT2157973E (ja)
RU (1) RU2469723C2 (ja)
SI (1) SI2157973T1 (ja)
TW (2) TWI489983B (ja)
UA (1) UA96633C2 (ja)
WO (1) WO2008143361A1 (ja)
ZA (1) ZA200908202B (ja)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2135607A1 (en) 2008-06-18 2009-12-23 Pharnext Combination of pilocarpin and methimazol for treating Charcot-MarieTooth disease and related disorders
US9387206B2 (en) 2009-11-03 2016-07-12 Pharnext Therapeutic approaches for treating Alzheimer's disease
EP2322163A1 (en) 2009-11-03 2011-05-18 Pharnext New therapeutics approaches for treating alzheimer disease
US9248111B2 (en) 2011-03-01 2016-02-02 Pharnext Therapeutic approaches for treating parkinson's disease
US9241933B2 (en) 2011-03-01 2016-01-26 Pharnext Compositions for treating amyotrophic lateral sclerosis
EP2727588B1 (en) 2011-03-01 2018-08-29 Pharnext Baclofen and acamprosate based therapy of neurological disorders
US10010515B2 (en) 2011-03-01 2018-07-03 Pharnext Therapeutic approaches for treating Parkinson's disease
KR20150027800A (ko) * 2012-06-15 2015-03-12 고에키 자이단 호징 센탄 이료 신코 자이단 경도 인지 장해의 예방 및/또는 치료제
US20160331922A1 (en) * 2013-12-23 2016-11-17 John W. Holaday Disposable container for air hydration
EP3459545A4 (en) * 2016-05-19 2020-02-26 National Cerebral and Cardiovascular Center MEDICINES FOR PREVENTING AND / OR TREATING DEMENTIA
CN111032038A (zh) 2017-05-24 2020-04-17 H.隆德贝克有限公司 用于治疗阿尔茨海默氏病的药物组合
CN107602523B (zh) * 2017-09-11 2020-08-18 安徽中医药大学 京尼平类似物、制备方法及其应用
PL237739B1 (pl) 2018-06-06 2021-05-17 Univ Gdanski Genisteina do zastosowania do leczenia choroby Alzheimera
NL2024431B1 (en) 2019-12-11 2021-09-07 Sulfateq Bv Compounds for treatment of alzheimer’s disease

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5535019A (en) 1978-09-01 1980-03-11 Otsuka Pharmaceut Co Ltd Carbostyryl derivative
JPS5649378A (en) 1979-08-25 1981-05-02 Otsuka Pharmaceut Co Ltd Tetrazolylalkoxycarbostyril derivative
FI95572C (fi) * 1987-06-22 1996-02-26 Eisai Co Ltd Menetelmä lääkeaineena käyttökelpoisen piperidiinijohdannaisten tai sen farmaseuttisen suolan valmistamiseksi
JP2574099B2 (ja) 1992-05-21 1997-01-22 大塚製薬株式会社 アレルギー疾患治療剤
JPH10175864A (ja) 1996-12-16 1998-06-30 Otsuka Pharmaceut Co Ltd 慢性閉塞性肺疾患治療剤
US6428488B1 (en) * 1997-08-28 2002-08-06 Kenneth Kensey Dual riser/dual capillary viscometer for newtonian and non-newtonian fluids
US6322524B1 (en) * 1997-08-28 2001-11-27 Visco Technologies, Inc. Dual riser/single capillary viscometer
US6019735A (en) * 1997-08-28 2000-02-01 Visco Technologies, Inc. Viscosity measuring apparatus and method of use
US6322525B1 (en) * 1997-08-28 2001-11-27 Visco Technologies, Inc. Method of analyzing data from a circulating blood viscometer for determining absolute and effective blood viscosity
WO1999036405A1 (en) * 1998-01-16 1999-07-22 Eisai Co., Ltd. Process for production of donepezil derivative
US6187790B1 (en) * 1999-03-04 2001-02-13 Neal R. Cutler Use of cilostazol for treatment of sexual dysfunction
US6267985B1 (en) * 1999-06-30 2001-07-31 Lipocine Inc. Clear oil-containing pharmaceutical compositions
US6294192B1 (en) * 1999-02-26 2001-09-25 Lipocine, Inc. Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
US6484565B2 (en) * 1999-11-12 2002-11-26 Drexel University Single riser/single capillary viscometer using mass detection or column height detection
US6458804B1 (en) * 2001-01-26 2002-10-01 R.T. Alamo Venturesi, Llc Methods for the treatment of central nervous system disorders in certain patient groups
TW200301135A (en) * 2001-12-27 2003-07-01 Otsuka Maryland Res Inst Inc Pharmaceutical compositions comprising a multifunctional phosphodiesterase inhibitor and an adenosine uptake inhibitor
IL150509A (en) * 2002-07-01 2007-07-04 Joseph Kaspi Pharmaceutical preparations containing donafazil hydrochloride
US6743806B2 (en) * 2002-10-23 2004-06-01 Otsuka Pharmaceutical Company, Limited Active oxygen scavenger
FR2848452B1 (fr) * 2002-12-12 2007-04-06 Aventis Pharma Sa Application des inhibiteurs de recapture intestinale des acides biliaires pour la prevention et le traitement de la maladie d'alzheimer
JP2004189706A (ja) * 2002-12-13 2004-07-08 Eisai Co Ltd 高度アルツハイマー型痴呆治療剤
TWI323660B (en) * 2003-02-25 2010-04-21 Otsuka Pharma Co Ltd Pten inhibitor or maxi-k channels opener

Also Published As

Publication number Publication date
JP2010527993A (ja) 2010-08-19
TW200904428A (en) 2009-02-01
RU2469723C2 (ru) 2012-12-20
UA96633C2 (uk) 2011-11-25
CN101754758A (zh) 2010-06-23
TW201412315A (zh) 2014-04-01
CA2687289C (en) 2015-09-15
SI2157973T1 (sl) 2015-10-30
KR20100020482A (ko) 2010-02-22
EP2937085B1 (en) 2019-07-10
BRPI0811919A2 (pt) 2014-11-18
IL202053A0 (en) 2010-06-16
EP2157973B1 (en) 2015-07-15
HRP20150843T1 (hr) 2015-09-11
EP2937085A1 (en) 2015-10-28
US20100298375A1 (en) 2010-11-25
MX2009012583A (es) 2010-03-08
HUE025902T2 (en) 2016-05-30
CA2687289A1 (en) 2008-11-27
RU2009147456A (ru) 2011-06-27
MY146407A (en) 2012-08-15
TWI489983B (zh) 2015-07-01
PL2157973T3 (pl) 2015-12-31
TWI423802B (zh) 2014-01-21
NZ581099A (en) 2012-03-30
PT2157973E (pt) 2015-10-14
EP2157973A1 (en) 2010-03-03
JP5153870B2 (ja) 2013-02-27
AR066664A1 (es) 2009-09-02
ZA200908202B (en) 2010-07-28
CN101754758B (zh) 2012-10-24
CO6251249A2 (es) 2011-02-21
ES2545959T3 (es) 2015-09-17
HK1215384A1 (zh) 2016-08-26
AU2008253977B2 (en) 2013-08-22
WO2008143361A1 (en) 2008-11-27
DK2157973T3 (en) 2015-08-17
AU2008253977A1 (en) 2008-11-27
CY1116683T1 (el) 2017-03-15
KR101441725B1 (ko) 2014-09-18
IL202053A (en) 2016-04-21

Similar Documents

Publication Publication Date Title
HK1140422A1 (en) A medicament comprising a carbostyril derivative and donepezil for treating alzheimers disease
HRP20190504T1 (hr) Doza farmaceutskog pripravka i cjepiva u krutom obliku
IL195668A0 (en) Amino-imidazolones and their use as a medicament for treating cognitive impairment, alzheimer disease, neurodegeneration and dementia
IL212915A0 (en) Pharmaceutical combination comprising a hsp 90 inhibitor and a mtor inhibitor
IL195574A0 (en) Amino-imidazolones and their use as a medicament for treating cognitive impairment, alzheimer disease, neurodegeneration and dementia
IL197316A0 (en) Buprenophine-wafer for drug substitution therapy
IL202014A0 (en) A synergistic pharmaceutical combination for the treatment of cancer
IL204728A0 (en) Methods and compounds for treating retinol-related diseases
ZA201004134B (en) 5-halogen-substituted oxindole derivatives and use thereof for treating vasopressine-dependent diseases
GB0719248D0 (en) Compounds and methods for pharmaceutical use
EP2025667A4 (en) 9, 10-SECOPREGNANDERIVAT AND MEDICINAL PRODUCTS
ZA201101752B (en) A medicinal product and treatment
ZA200808076B (en) Methods for preventing and treating amyloidogenic diseases
IL197125A0 (en) Drug combinations for treating airway diseases
EP2005964A4 (en) MEDICAMENT FOR TREATING HYPERPHOSPHATEEMIA AND PREPARATION METHOD THEREOF
IL185637A (en) An instrument for the treatment and prevention of infectious diseases
EP2116538A4 (en) CONDENSED TETRAHYDROQUINOLINE DERIVATIVE AND ITS USE FOR MEDICAL PURPOSES
EP2146726A4 (en) DIHYDROPYRIDINE DERIVATIVE FOR THE TREATMENT OF CANCER OR PRE-ACUTE DISORDER AND OTHER DISORDERS
GB2447884B (en) Treatment for skin disease
HK1120034A1 (en) Pharmaceuticals for treating or preventing oral diseases
GB0811950D0 (en) Disease prevention and treatment
GB0604130D0 (en) Treatment for skin disease
GB0801441D0 (en) Drugs against cancer and infectious diseases
GB0705781D0 (en) Drugs against cancer and infectious diseases

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20210525